These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11894724)

  • 1. Cholesterol reduction in patients with lower limb atherosclerotic disease.
    Bismuth J; Kofoed SC; Sillesen HH
    Dan Med Bull; 2002 Feb; 49(1):61-4. PubMed ID: 11894724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid lowering treatment of patients with atherosclerotic disease of the lower extremities].
    Bismuth J; Kofoed SC; Sillesen HH
    Ugeskr Laeger; 2001 Dec; 163(49):6882-5. PubMed ID: 11766498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Why are cardiologists to be concerned about obliterating arterial disease of the lower leg?].
    Fisicaro M
    Ital Heart J Suppl; 2003 Apr; 4(4):306-18. PubMed ID: 12784766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cholesterol abnormalities.
    Lockman AR; Tribastone AD; Knight KV; Franko JP
    Am Fam Physician; 2005 Mar; 71(6):1137-42. PubMed ID: 15791891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
    Chi YW; Jaff MR
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beyond cholesterol levels: new therapeutic indications of statins].
    De Luca N
    Recenti Prog Med; 2001; 92(7-8):429-32. PubMed ID: 11475783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease.
    Taute BM; Taute R; Heins S; Behrmann C; Podhaisky H
    Int Angiol; 2004 Mar; 23(1):35-40. PubMed ID: 15156128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
    Singer DR; Kite A
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment in the patient with established peripheral arterial disease.
    Haugen S; Casserly IP; Regensteiner JG; Hiatt WR
    Vasc Med; 2007 Nov; 12(4):343-50. PubMed ID: 18048472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease.
    Blinc A; Poredos P
    Eur J Clin Invest; 2007 Mar; 37(3):157-64. PubMed ID: 17359482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can ischaemic stroke be prevented with statins?].
    Dahl A; Russell D
    Tidsskr Nor Laegeforen; 2005 Mar; 125(5):575-7. PubMed ID: 15776029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of peripheral arterial occlusive disease with major coronary events in a mediterranean population with low coronary heart disease incidence.
    Merino J; Planas A; De Moner A; Gasol A; Contreras C; Marrugat J; Vidal-Barraquer F; Clarà A
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):71-6. PubMed ID: 18396072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of peripheral arterial disease: a comprehensive review.
    Stoyioglou A; Jaff MR
    J Vasc Interv Radiol; 2004 Nov; 15(11):1197-207. PubMed ID: 15525738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
    Cavendish JJ; Safani M
    Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of two coronary risk equivalents: diabetes mellitus and peripheral arterial disease].
    Darius H; Trampisch HJ; Pittrow D; Allenberg JR; Haberl RL; Mahn M; Tepohl HG; Burghaus I; Diehm C
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2317-22. PubMed ID: 18958826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can functional performance be used as a simple prognostic indicator in peripheral arterial disease?
    Olin JW
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):686-7. PubMed ID: 18779831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.